dc.creatorQUEIROZ, Regina Helena Costa
dc.creatorBERTUCCI, Carlo
dc.creatorMALFARA, Wilson Roberto
dc.creatorDREOSSI, Sonia Aparecida Carvalho
dc.creatorCHAVES, Andrea Rodrigues
dc.creatorVALERIO, Daniel Augusto Rodrigues
dc.creatorQUEIROZ, Maria Eugenia Costa
dc.date.accessioned2012-10-19T14:14:24Z
dc.date.accessioned2018-07-04T15:00:37Z
dc.date.available2012-10-19T14:14:24Z
dc.date.available2018-07-04T15:00:37Z
dc.date.created2012-10-19T14:14:24Z
dc.date.issued2008
dc.identifierJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, v.48, n.2, Special Issue, p.428-434, 2008
dc.identifier0731-7085
dc.identifierhttp://producao.usp.br/handle/BDPI/20735
dc.identifier10.1016/j.jpba.2008.03.020
dc.identifierhttp://dx.doi.org/10.1016/j.jpba.2008.03.020
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1617514
dc.description.abstractA sensitive and reproducible stir bar-sorptive extraction and high-performance liquid chromatography-UV detection (SBSE/HPLC-UV) method for therapeutic drug monitoring of carbamazepine, carbamazepine-10,11-epoxide, phenytoin and phenobarbital in plasma samples is described and compared with a liquid:liquid extraction (LLE/HPLC-UV) method. Important factors in the optimization of SBSE efficiency such as pH, extraction time and desorption conditions (solvents, mode magnetic stir, mode ultrasonic stir, time and number of steps) assured recoveries ranging from 72 to 86%, except for phenytoin (62%). Separation was obtained using a reverse phase C-18 column with UV detection (210 nm). The mobile phase consisted of water: acetonitrile (78:22, v/v). The SBSE/HPLC-UV method was linear over a working range of 0.08-40.0 mu g mL(-1) for carbamazepine, carbamazepine-10,11-epoxide and phenobarbital and 0.125-40.0 mu g mL(-1) for phenytoin, The intra-assay and inter-assay precision and accuracy were studied at three concentrations (1.0, 4.0 and 20.0 mu g mL(-1)). The intra-assay coefficients of variation (CVs) for all compounds were less than 8.8% and all inter-CVs were less than 10%. Limits of quantification were 0.08 mu g mL(-1) for carbamazepine, carbamazepine-10,11-epoxide and phenobarbital and 0.125 mu g mL(-1) for phenytoin. No interference of the drugs normally associated with antiepileptic drugs was observed. Based on figures of merit results, the SBSE/HPLC-UV proved adequate for antiepileptic drugs analyses from therapeutic levels. This method was successfully applied to the analysis of real samples and was as effective as the LLE/HPLC-UV method. (c) 2008 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.relationJournal of Pharmaceutical and Biomedical Analysis
dc.rightsCopyright PERGAMON-ELSEVIER SCIENCE LTD
dc.rightsrestrictedAccess
dc.subjectstir bar-sorptive extraction
dc.subjecthigh-performance liquid chromatography
dc.subjectcarbamazepine
dc.subjectcarbamazepine-10,11-epoxide
dc.subjectphenytoin
dc.subjectphenobarbital
dc.subjecttherapeutic drug monitoring
dc.titleQuantification of carbamazepine, carbamazepine-10,11-epoxide, phenytoin and phenobarbital in plasma samples by stir bar-sorptive extraction and liquid chromatography
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución